Virpax Pharmaceuticals Shares Surge After Reporting Positive Results for Prospective Pain Drug

MT Newswires Live11-22 22:36

Virpax Pharmaceuticals (VRPX) surged in recent Friday trading after the specialty medications company said injections of its Probudur drug candidate into tissue surrounding an incisional wound provided both immediate and extended pain relief in minipigs during preclinical testing to determine optimal dosing ranges.

All of the minipigs in the study showed positive tolerance to Probudur and had no adverse effects. Based on the positive results, Virpax said it would continue to work on developing human trials for Probudur as part of an eventual investigational new drug application.

The company's shares were up 47% in recent trading Friday.

Price: 0.83, Change: +0.26, Percent Change: +47.50

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment